Product Information

ERY-TAB DR 333 MG TABLET is a generic product labeled by Arbor Pharmaceuticals, Inc., priced at $2.8030 per EA under NDC 24338012403. Its NADAC has been published 186 times since Feb 7, 2018.

FDA first approved this application before 1982. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

ERY-TAB DR 333 MG TABLET

Erythromycin
$2.8030per EA

Strength

333 mg/1

NDC

24338012403

Classification

Generic

Dosage Form

TABLET, DELAYED RELEASE

Route

ORAL

Effective Date

11/18/2026

Active Ingredients

ERYTHROMYCIN

Approval Type

Generic (ANDA)

FDA Application

ANDA062298

FDA Approved

Before 1982

TE Code

AB

On Market Since

4/18/2011

Pharmacological Classes

Decreased Sebaceous Gland Activity
Macrolide Antimicrobial
Macrolide
Macrolides

Price Statistics

The NADAC for ERY-TAB DR 333 MG TABLET has been published 186 times since Feb 7, 2018, and over the history we have for it it has declined 67.1%. The table below summarizes its recorded NADAC range and movement.

Current price$2.8030 per EA
All-time high$8.5150 (Jan 16, 2019)
All-time low$2.5179 (Aug 21, 2024)
52-week high$3.7275
52-week low$2.8030
Median price$3.6002
Average price$4.7615
Largest weekly change-60.1% (Apr 17, 2024)
Weeks tracked186
Tracking sinceFeb 7, 2018

Price History

1W

-3.4%

1M

-14.0%

3M

-21.8%

6M

-17.6%

1Y

-22.1%

3Y

-67.1%

5Y

-67.1%

All

-67.1%

Generic Alternatives

The matcher finds 3 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Continue researching this drug

Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.

Frequently asked questions

What is the NADAC price of ERY-TAB DR 333 MG TABLET?

The current National Average Drug Acquisition Cost (NADAC) for ERY-TAB DR 333 MG TABLET, manufactured by Arbor Pharmaceuticals, Inc., is $2.8030 per EA (NDC 24338012403), effective Nov 18, 2026.

How has the price of ERY-TAB DR 333 MG TABLET changed over time?

Over the history we have for it, the NADAC for ERY-TAB DR 333 MG TABLET has declined 67.1%. It has been tracked across 186 weekly CMS publications since Feb 7, 2018.

What are the highest and lowest recorded NADAC prices for ERY-TAB DR 333 MG TABLET?

Since Feb 7, 2018, the NADAC for ERY-TAB DR 333 MG TABLET has ranged from a low of $2.5179 (Aug 21, 2024) to a high of $8.5150 (Jan 16, 2019), with a median of $3.6002 per EA.

Are there cheaper alternatives to ERY-TAB DR 333 MG TABLET?

3 manufacturers publish a NADAC-priced product with the same active ingredient and strength as ERY-TAB DR 333 MG TABLET in a comparable dosage form, but none are currently priced below it.

Who manufactures ERY-TAB DR 333 MG TABLET?

ERY-TAB DR 333 MG TABLET (NDC 24338012403) is labeled by Arbor Pharmaceuticals, Inc., and CMS classifies it as a generic product.